All references on this page are limited to identity, supply format, storage context, documentation relevance, and procurement transparency for laboratories and research buyers
The evaluating clinician determines whether treatment is appropriate, and a prescription is not guaranteed
SNX-0723, identified through scaffold-based screening, selectively binds the ATP-binding pocket of HSP90 and demonstrates improved brain penetration, reducing mutant huntingtin aggregation in PD and HD models
Some of the important products it employs include Avastin to treat solid tumors, Herceptin to treat HER2-positive breast cancer, and Rituxan to treat hematologic tumors and autoimmune diseases
Currently, there is no evidence suggesting that GLP-1 medications reduce effectives of non-oral contraception
Store at room temperature (1-30C), before reconstitution